Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells

Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental hematology 2007-05, Vol.35 (5), p.782-792
Hauptverfasser: Rozenveld-Geugien, Marjan, Baas, Inge O, van Gosliga, Djoke, Vellenga, Edo, Schuringa, Jan Jacob
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 792
container_issue 5
container_start_page 782
container_title Experimental hematology
container_volume 35
creator Rozenveld-Geugien, Marjan
Baas, Inge O
van Gosliga, Djoke
Vellenga, Edo
Schuringa, Jan Jacob
description Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.
doi_str_mv 10.1016/j.exphem.2007.02.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70620388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301472X07001117</els_id><sourcerecordid>70620388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</originalsourceid><addsrcrecordid>eNqFkUuLFDEQx4Mo7rj6DURy8ta9lWSm07kIsqwPWBB8gLeQTlc7me1OepP0unvyq5t2BgQvngLh_6j6FSEvGdQMWHNxqPF-3uNUcwBZA68Bmkdkw1opKi6Uekw2IIBVW8m_n5FnKR0AYLdT8JScMbmTUnG5Ib-u7mfjkwuehoH6ECczUuN7OuJyg5OzdL9MxtNSZHKYg8Nc_lLG6WKO4Qd6l0OkFscx0Yi3i4uY6Gdjqwl7ZzL21PmM0di8Vvx0eV_MMawtf0zPyZPBjAlfnN5z8u3d1dfLD9X1p_cfL99eV3bbsFzhTnVSNHyAjtsOuYBWmsZ0fWegEX2nJMKgGqO6vpVbCay3AjlaxoSSDTfinLw-5papbxdMWU8urRMYj2FJWkLDQbRtEW6PQhtDShEHPUc3mfigGegVvD7oI3i9gtfAdQFfbK9O-UtXVv9rOpEugjdHAZYt7xxGnaxDbwumiDbrPrj_NfwbYEfnnTXjDT5gOoQl-kJQM52KQX9Zj7_eHiQAY0yK3wnIrtk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70620388</pqid></control><display><type>article</type><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</creator><creatorcontrib>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</creatorcontrib><description>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</description><identifier>ISSN: 0301-472X</identifier><identifier>EISSN: 1873-2399</identifier><identifier>DOI: 10.1016/j.exphem.2007.02.006</identifier><identifier>PMID: 17577927</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Advanced Basic Science ; Aminoquinolines - pharmacology ; Antigens, CD34 - immunology ; Cell Adhesion - drug effects ; Cell Adhesion - physiology ; Cell Communication - physiology ; Cell Culture Techniques - methods ; Cell Movement - drug effects ; Cell Movement - physiology ; Cell Proliferation - drug effects ; Dose-Response Relationship, Drug ; Hematology, Oncology and Palliative Medicine ; Hematopoietic Stem Cells - cytology ; Hematopoietic Stem Cells - drug effects ; Hematopoietic Stem Cells - physiology ; Humans ; Leukemia, Myeloid - metabolism ; Neoplastic Stem Cells ; Pyrimidines - pharmacology ; rac GTP-Binding Proteins - antagonists &amp; inhibitors ; rac GTP-Binding Proteins - physiology ; Signal Transduction - drug effects ; Signal Transduction - physiology ; Stromal Cells - cytology ; Stromal Cells - drug effects ; Stromal Cells - physiology</subject><ispartof>Experimental hematology, 2007-05, Vol.35 (5), p.782-792</ispartof><rights>International Society for Experimental Hematology</rights><rights>2007 International Society for Experimental Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</citedby><cites>FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.exphem.2007.02.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17577927$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rozenveld-Geugien, Marjan</creatorcontrib><creatorcontrib>Baas, Inge O</creatorcontrib><creatorcontrib>van Gosliga, Djoke</creatorcontrib><creatorcontrib>Vellenga, Edo</creatorcontrib><creatorcontrib>Schuringa, Jan Jacob</creatorcontrib><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><title>Experimental hematology</title><addtitle>Exp Hematol</addtitle><description>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</description><subject>Advanced Basic Science</subject><subject>Aminoquinolines - pharmacology</subject><subject>Antigens, CD34 - immunology</subject><subject>Cell Adhesion - drug effects</subject><subject>Cell Adhesion - physiology</subject><subject>Cell Communication - physiology</subject><subject>Cell Culture Techniques - methods</subject><subject>Cell Movement - drug effects</subject><subject>Cell Movement - physiology</subject><subject>Cell Proliferation - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Hematopoietic Stem Cells - cytology</subject><subject>Hematopoietic Stem Cells - drug effects</subject><subject>Hematopoietic Stem Cells - physiology</subject><subject>Humans</subject><subject>Leukemia, Myeloid - metabolism</subject><subject>Neoplastic Stem Cells</subject><subject>Pyrimidines - pharmacology</subject><subject>rac GTP-Binding Proteins - antagonists &amp; inhibitors</subject><subject>rac GTP-Binding Proteins - physiology</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - physiology</subject><subject>Stromal Cells - cytology</subject><subject>Stromal Cells - drug effects</subject><subject>Stromal Cells - physiology</subject><issn>0301-472X</issn><issn>1873-2399</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUuLFDEQx4Mo7rj6DURy8ta9lWSm07kIsqwPWBB8gLeQTlc7me1OepP0unvyq5t2BgQvngLh_6j6FSEvGdQMWHNxqPF-3uNUcwBZA68Bmkdkw1opKi6Uekw2IIBVW8m_n5FnKR0AYLdT8JScMbmTUnG5Ib-u7mfjkwuehoH6ECczUuN7OuJyg5OzdL9MxtNSZHKYg8Nc_lLG6WKO4Qd6l0OkFscx0Yi3i4uY6Gdjqwl7ZzL21PmM0di8Vvx0eV_MMawtf0zPyZPBjAlfnN5z8u3d1dfLD9X1p_cfL99eV3bbsFzhTnVSNHyAjtsOuYBWmsZ0fWegEX2nJMKgGqO6vpVbCay3AjlaxoSSDTfinLw-5papbxdMWU8urRMYj2FJWkLDQbRtEW6PQhtDShEHPUc3mfigGegVvD7oI3i9gtfAdQFfbK9O-UtXVv9rOpEugjdHAZYt7xxGnaxDbwumiDbrPrj_NfwbYEfnnTXjDT5gOoQl-kJQM52KQX9Zj7_eHiQAY0yK3wnIrtk</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Rozenveld-Geugien, Marjan</creator><creator>Baas, Inge O</creator><creator>van Gosliga, Djoke</creator><creator>Vellenga, Edo</creator><creator>Schuringa, Jan Jacob</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</title><author>Rozenveld-Geugien, Marjan ; Baas, Inge O ; van Gosliga, Djoke ; Vellenga, Edo ; Schuringa, Jan Jacob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-e59b7362f0b2cbe23087a6abdba063db97e0f96a9bd874701dc3e2ec1139762a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Advanced Basic Science</topic><topic>Aminoquinolines - pharmacology</topic><topic>Antigens, CD34 - immunology</topic><topic>Cell Adhesion - drug effects</topic><topic>Cell Adhesion - physiology</topic><topic>Cell Communication - physiology</topic><topic>Cell Culture Techniques - methods</topic><topic>Cell Movement - drug effects</topic><topic>Cell Movement - physiology</topic><topic>Cell Proliferation - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Hematopoietic Stem Cells - cytology</topic><topic>Hematopoietic Stem Cells - drug effects</topic><topic>Hematopoietic Stem Cells - physiology</topic><topic>Humans</topic><topic>Leukemia, Myeloid - metabolism</topic><topic>Neoplastic Stem Cells</topic><topic>Pyrimidines - pharmacology</topic><topic>rac GTP-Binding Proteins - antagonists &amp; inhibitors</topic><topic>rac GTP-Binding Proteins - physiology</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - physiology</topic><topic>Stromal Cells - cytology</topic><topic>Stromal Cells - drug effects</topic><topic>Stromal Cells - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rozenveld-Geugien, Marjan</creatorcontrib><creatorcontrib>Baas, Inge O</creatorcontrib><creatorcontrib>van Gosliga, Djoke</creatorcontrib><creatorcontrib>Vellenga, Edo</creatorcontrib><creatorcontrib>Schuringa, Jan Jacob</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rozenveld-Geugien, Marjan</au><au>Baas, Inge O</au><au>van Gosliga, Djoke</au><au>Vellenga, Edo</au><au>Schuringa, Jan Jacob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells</atitle><jtitle>Experimental hematology</jtitle><addtitle>Exp Hematol</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>35</volume><issue>5</issue><spage>782</spage><epage>792</epage><pages>782-792</pages><issn>0301-472X</issn><eissn>1873-2399</eissn><abstract>Objective To determine the involvement of Rac signaling in self-renewal and expansion on bone marrow stroma of normal CD34+ cells vs leukemic CD34+ cells from acute myeloid leukemia (AML) patients. Materials and Methods Rac signaling was modulated by retroviral introduction of Rac1-N17, Rac1-V12, or by using the Rac inhibitor NSC23766. In long-term MS5 cocultures (leukemic) expansion, migration, adhesion, and presence of stem/progenitor cells were monitored in both normal as well as leukemic CD34+ cells. Results Inhibition of Rac signaling impaired migration and adhesion of cord blood (CB) CD34+ cells on MS5 stroma. Long-term inhibition of Rac during a 5-week coculture period on stroma prevented association of hematopoietic progenitors with the bone marrow stromal cells and resulted in a dramatic decrease in the primitive stem cell frequency (long-term culture-initiating cell) in a dose-dependent manner. Many of these phenotypes were reversed in the presence of activated Rac1-V12, including improved migration toward, and association with, MS5 cells. CD34+ AML cells were characterized by elevated levels of Rac activity (five of seven patients) and enhanced migration and adhesion to MS5 bone marrow stroma as compared to CB CD34+ cells. A dramatic decrease was observed in the formation of leukemic cobblestone area–forming cells as well as strongly diminished clonal expansion in the presence of the Rac inhibitor NSC23766. Conclusion Our data indicate that Rac signal transduction is required for the maintenance and expansion of both normal as well as leukemic stem/progenitor cells by mediating their interaction with stromal cells.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>17577927</pmid><doi>10.1016/j.exphem.2007.02.006</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0301-472X
ispartof Experimental hematology, 2007-05, Vol.35 (5), p.782-792
issn 0301-472X
1873-2399
language eng
recordid cdi_proquest_miscellaneous_70620388
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Advanced Basic Science
Aminoquinolines - pharmacology
Antigens, CD34 - immunology
Cell Adhesion - drug effects
Cell Adhesion - physiology
Cell Communication - physiology
Cell Culture Techniques - methods
Cell Movement - drug effects
Cell Movement - physiology
Cell Proliferation - drug effects
Dose-Response Relationship, Drug
Hematology, Oncology and Palliative Medicine
Hematopoietic Stem Cells - cytology
Hematopoietic Stem Cells - drug effects
Hematopoietic Stem Cells - physiology
Humans
Leukemia, Myeloid - metabolism
Neoplastic Stem Cells
Pyrimidines - pharmacology
rac GTP-Binding Proteins - antagonists & inhibitors
rac GTP-Binding Proteins - physiology
Signal Transduction - drug effects
Signal Transduction - physiology
Stromal Cells - cytology
Stromal Cells - drug effects
Stromal Cells - physiology
title Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires Rac-mediated interaction with stromal cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expansion%20of%20normal%20and%20leukemic%20human%20hematopoietic%20stem/progenitor%20cells%20requires%20Rac-mediated%20interaction%20with%20stromal%20cells&rft.jtitle=Experimental%20hematology&rft.au=Rozenveld-Geugien,%20Marjan&rft.date=2007-05-01&rft.volume=35&rft.issue=5&rft.spage=782&rft.epage=792&rft.pages=782-792&rft.issn=0301-472X&rft.eissn=1873-2399&rft_id=info:doi/10.1016/j.exphem.2007.02.006&rft_dat=%3Cproquest_cross%3E70620388%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70620388&rft_id=info:pmid/17577927&rft_els_id=S0301472X07001117&rfr_iscdi=true